A comprehensive view of Decibel Therapeutics Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Regeneron to acquire clinical-stage biotechnology firm Decibel Therapeutics for US$109M; the two firms have been collaborating since 2017 and are developing three gene therapy programs targeting different forms of congenital, monogenic hearing loss
Published: August 11, 2023 by Regeneron Pharmaceuticals Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count